Table 2.
Demographics and clinical features of aPE. Blood laboratory data and instrumental tests of patients of “non-massive aPE” and “massive aPE” groups
| “Non-massive aPE” group (n = 82) | “Massive aPE” group (n = 24) | p | |
|---|---|---|---|
| Age (years) | Min 38 Max 93 | Min 37 Max 89 | 0.935 |
| Mean 67.5 ± 14.6 | Mean 69 ± 14 | ||
| D-dimer (μg/L) | Min 265 Max 25150 | Min 1035 Max 20500 | 0.638 |
| Mean 4531 ± 4685 | Mean 6872 ± 5775 | ||
| CRP (mg/L) | Min 1.1 Max 216 | Min 9.5 Max 99 | 0.130 |
| Mean 60 ± 52 | Mean 36 ± 28 | ||
| Dyspnea | 72 (88%) | 23 (96%) | 0.257 |
| Weakness | 51 (62%) | 16 (67%) | 0.690 |
| Chest pain | 46 (56%) | 10 (42%) | 0.121 |
| Cough | 39 (48%) | 4 (17%) | 0.007 |
| Fever | 36 (44%) | 3 (13%) | 0.005 |
| Haemoptysis | 16 (20%) | 1 (4%) | 0.072 |
| Syncope | 9 (11%) | 10 (42%) | 0.001 |
| Right ventricular dysfunction | 27 (50%) | 19 (86%) | 0.003 |
| Pleural effusion | 39 (48%) | 6 (25%) | 0.049 |
| Opacity/consolidation on chest CT | 26 (32%) | 5 (21%) | 0.303 |